DexCom Net Income Applicable To Common Shares from 2010 to 2026

DC4 Stock  EUR 61.93  0.59  0.96%   
DexCom's Net Income Applicable To Common Shares is increasing over the last several years with slightly volatile swings. Net Income Applicable To Common Shares is estimated to finish at about 412 M this year. Net Income Applicable To Common Shares is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
 
Net Income Applicable To Common Shares  
First Reported
2016-12-31
Previous Quarter
120.7 M
Current Value
120.7 M
Quarterly Volatility
88.5 M
 
Covid
 
Interest Hikes
Check DexCom financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DexCom's main balance sheet or income statement drivers, such as Interest Expense of 31.7 M, Selling General Administrative of 742.9 M or Total Revenue of 4.9 B, as well as many indicators such as . DexCom financial statements analysis is a perfect complement when working with DexCom Valuation or Volatility modules.
  
This module can also supplement various DexCom Technical models . Check out the analysis of DexCom Correlation against competitors.
The Net Income Applicable To Common Shares trend for DexCom Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether DexCom is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest DexCom's Net Income Applicable To Common Shares Growth Pattern

Below is the plot of the Net Income Applicable To Common Shares of DexCom Inc over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. DexCom's Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DexCom's overall financial position and show how it may be relating to other accounts over time.
Net Income Applicable To Common Shares10 Years Trend
Slightly volatile
   Net Income Applicable To Common Shares   
       Timeline  

DexCom Net Income Applicable To Common Shares Regression Statistics

Arithmetic Mean134,304,647
Coefficient Of Variation161.69
Mean Deviation194,640,761
Median(22,400,000)
Standard Deviation217,163,143
Sample Variance47159.8T
Range676.8M
R-Value0.80
Mean Square Error18103.3T
R-Squared0.64
Significance0.0001
Slope34,406,990
Total Sum of Squares754557.3T

DexCom Net Income Applicable To Common Shares History

2026412 M
2025392.4 M
2022341.2 M
2021216.9 M
2020549.7 M
2019101.1 M
2018-127.1 M

About DexCom Financial Statements

DexCom stakeholders use historical fundamental indicators, such as DexCom's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although DexCom investors may analyze each financial statement separately, they are all interrelated. For example, changes in DexCom's assets and liabilities are reflected in the revenues and expenses on DexCom's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in DexCom Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Income Applicable To Common Shares392.4 M412 M

Currently Active Assets on Macroaxis

When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:
Check out the analysis of DexCom Correlation against competitors.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
It's important to distinguish between DexCom's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DexCom should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, DexCom's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.